New Technology– category –
-
Applied Materials Unveils New Systems to Accelerate DRAM and Advanced Packaging for AI Chips
Applied Materials, Inc. USA Overview Applied Materials has introduced a suite of new material engineering systems designed to accelerate the manufacturing of advanced 3D chip architectures crucial for next-generation AI. These innovation... -
Boehringer Ingelheim Fuels Immunai’s AI with $15M to Unlock T-Cell Secrets for Cancer, Autoimmune Drug Discovery
Fierce Biotech USA Overview Boehringer Ingelheim (BI) has invested $15 million in Immunai's advanced AI platform, initiating a collaborative research agreement. This partnership aims to accelerate drug discovery for cancer and autoimmune... -
Bayer and Iambic Therapeutics Partner to Drive Small Molecule Drug Discovery with AI Platform
BioSpace USA Overview Bayer has announced a strategic collaboration with Iambic Therapeutics, leveraging Iambic's advanced AI platforms, Enchant and NeuralPLexer, for small molecule drug discovery. This partnership aims to significantly ... -
MAIA Biotechnology Completes Global Enrollment for Phase 2 Ateganosine Trial in Refractory NSCLC
GlobeNewswire USA Overview MAIA Biotechnology has completed global enrollment for Part C of its Phase 2 THIO-101 expanded trial, evaluating ateganosine for third-line advanced non-small cell lung cancer (NSCLC). Ateganosine, an investiga... -
HHS Unveils Strategy to Accelerate US Drug Discovery, Stemming Clinical Trial Shift to China
BioPharma Dive USA Overview The U.S. Department of Health and Human Services (HHS) has launched a comprehensive initiative to accelerate early-stage drug research domestically, directly countering the recent trend of clinical trials migr... -
Vertex AI-Designed Candidates Hit Phase 1/2 Trials, Accelerating AI-Driven Drug Discovery
Vertex AI Search (PharmaJournalist) USA Overview Multiple AI-designed drug candidates, developed using Vertex AI Search, have advanced to Phase 1 and 2 clinical trials, firmly establishing AI as a pivotal force in pharmaceutical R&D.... -
HHS Launches Cross-Agency Initiative to Restore US Clinical Trial Leadership, Leveraging AI/ML for Enhanced Safety & Efficiency
HHS.gov USA Overview The U.S. Department of Health and Human Services (HHS) has launched a landmark cross-agency initiative to restore the nation's leadership in clinical trials. This effort integrates artificial intelligence (AI) and ma... -
ClinicalTrials.gov Completes Modern Platform Migration, Dramatically Elevating Clinical Trial Data Access and Transparency
ClinicalTrials.gov USA Overview ClinicalTrials.gov has successfully transitioned to a modernized Protocol Registration and Results System (PRS) platform, significantly enhancing the accessibility and transparency of clinical trial inform... -
FDA Greenlights Breakthrough TNBC Therapies, First-in-Class Hypertriglyceridemia Drug, and New Breast Cancer Maintenance Regimen
FDA USA Overview On June 24, 2026, the U.S. FDA announced pivotal approvals across several cancer and metabolic disease indications, introducing significant new therapeutic options. These include a breakthrough for triple-negative breast... -
Oral GLP-1 Aleniglipron Achieves 12% Weight Loss in Phase II, Poised to Transform Obesity Treatment
Health and Me / Northwestern University USA Overview The novel oral GLP-1 receptor agonist, aleniglipron, demonstrated an impressive average 12% body weight reduction over 36 weeks in obese or overweight patients during a Phase II clinic...
